93 results
Page 3 of 5
8-K
EX-99.1
mzbgq zr1hq4uns0e
7 Jan 21
Regulation FD Disclosure
7:51am
8-K
EX-99.1
n1kvx50g5u4 6hqsfrou
20 May 20
Regulation FD Disclosure
7:43am
8-K
EX-99.2
4tbtf 0acovrfp
3 Dec 19
Aldeyra Therapeutics Announces PositiveTop-Line Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease
7:43am
8-K
EX-99.1
lq0zj8
31 Oct 19
Regulation FD Disclosure
7:38am
8-K
EX-99.1
1sd75r g369
25 Jun 19
Regulation FD Disclosure
8:00am
8-K
EX-99.1
cs9uppx2wc9t 3j
6 Jun 19
Submission of Matters to a Vote of Security Holders
6:31am
8-K
EX-99.1
hrko3f7av
26 Mar 19
Entry into a Material Definitive Agreement
7:53am
8-K
EX-99.1
qpa 2cxbi7pfd
28 Feb 19
Regulation FD Disclosure
7:21am
8-K
EX-2.1
4thm5zxza
29 Jan 19
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
8:16am
424B5
ngcsqckq 3ilo
28 Dec 18
Prospectus supplement for primary offering
4:19pm